AR004178A1 - Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. - Google Patents

Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.

Info

Publication number
AR004178A1
AR004178A1 ARP960103748A AR10374896A AR004178A1 AR 004178 A1 AR004178 A1 AR 004178A1 AR P960103748 A ARP960103748 A AR P960103748A AR 10374896 A AR10374896 A AR 10374896A AR 004178 A1 AR004178 A1 AR 004178A1
Authority
AR
Argentina
Prior art keywords
procedure
formulation
pharmacy
pharmaceutical composition
same
Prior art date
Application number
ARP960103748A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR004178A1 publication Critical patent/AR004178A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP960103748A 1995-07-29 1996-07-25 Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. AR004178A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Publications (1)

Publication Number Publication Date
AR004178A1 true AR004178A1 (es) 1998-11-04

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103748A AR004178A1 (es) 1995-07-29 1996-07-25 Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.

Country Status (25)

Country Link
EP (1) EP0841902A2 (xx)
JP (1) JPH11510493A (xx)
KR (1) KR19990035972A (xx)
CN (1) CN1196677A (xx)
AP (1) AP858A (xx)
AR (1) AR004178A1 (xx)
AU (1) AU716961B2 (xx)
BG (1) BG102266A (xx)
BR (1) BR9609804A (xx)
CA (1) CA2228048A1 (xx)
CZ (1) CZ24798A3 (xx)
DZ (1) DZ2077A1 (xx)
EA (2) EA000740B1 (xx)
HU (1) HUP9900521A3 (xx)
IL (1) IL122897A0 (xx)
MA (1) MA23953A1 (xx)
MX (1) MX9800809A (xx)
NO (1) NO980384L (xx)
NZ (1) NZ315632A (xx)
OA (1) OA10659A (xx)
PL (1) PL325242A1 (xx)
SK (1) SK11098A3 (xx)
TR (1) TR199800156T1 (xx)
UY (1) UY24297A1 (xx)
WO (1) WO1997004750A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
US6451343B1 (en) * 1998-03-11 2002-09-17 Smithkline Beecham Corporation Composition for treating dementia and Alzheimer's disease
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
WO2002047693A2 (en) 2000-12-14 2002-06-20 Ortho-Mcneil Pharmaceutical, Inc. Steroid hormone products comprising a stabilizing agent in non-crystalline form
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
DK0392803T3 (da) * 1989-04-13 2004-10-18 Beecham Group Plc Hidtil ukendte forbindelser
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
CA2228048A1 (en) 1997-02-13
NZ315632A (en) 1999-11-29
CZ24798A3 (cs) 1998-06-17
WO1997004750A3 (en) 1997-03-27
BG102266A (en) 1998-10-30
BR9609804A (pt) 1999-07-06
CN1196677A (zh) 1998-10-21
EA199800179A1 (ru) 1998-10-29
OA10659A (en) 2002-09-18
EP0841902A2 (en) 1998-05-20
AP9801170A0 (en) 1998-01-31
UY24297A1 (es) 1997-01-23
AU6738496A (en) 1997-02-26
PL325242A1 (en) 1998-07-06
IL122897A0 (en) 1998-08-16
EA199901055A1 (ru) 2000-06-26
MX9800809A (es) 1998-04-30
AP858A (en) 2000-07-12
SK11098A3 (en) 1998-07-08
AU716961B2 (en) 2000-03-09
MA23953A1 (fr) 1997-04-01
HUP9900521A2 (hu) 1999-06-28
HUP9900521A3 (en) 2001-04-28
NO980384D0 (no) 1998-01-28
DZ2077A1 (fr) 2002-07-22
KR19990035972A (ko) 1999-05-25
EA000740B1 (ru) 2000-02-28
NO980384L (no) 1998-03-26
JPH11510493A (ja) 1999-09-14
TR199800156T1 (xx) 1998-04-21
WO1997004750A2 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
PT101061A (pt) Composicoes farmaceuticas contendo anagolos da camptotecina e um composto de coordenacao de platina e seu uso na inibicao do crescimento de celulas tumorais
EE03177B1 (et) Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ZA921875B (en) New esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
IT1199962B (it) Ciclosporine,processi per la loro preparazione,uso farmaceutico delle stesse e composizioni farmaceutiche che le contengono
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
ITMO920035A1 (it) Flacone contagocce particolarmente per prodotti farmaceutici attivabili all'uso per miscelazione
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
MX9401080A (es) Compuestos heteroaromaticos.
AR004178A1 (es) Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.
IT1237474B (it) Composti tripeptidici e loro uso farmaceutico come immuno-modulatori
PA8496701A1 (es) Polimorfos de un diclorhidrato cristalino de azobiciclo [2.2.2] oct- 3 - ilamina y sus composiciones farmaceuticas
IL67925A0 (en) Laevorotatory isomer of mequitazine,its preparation and pharmaceutical compositions containing it
BR9710038A (pt) Novas composições e matrizes radiofarmacêuticas e seus usos.
FI822671L (fi) Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel
IL91813A0 (en) Pharmaceutical compositions containing stable oxapenem-3-carboxylic acids and their preparation
MX9302578A (es) Agentes antivirales.
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal